Human monoamine oxidase A gene determines levels of enzyme activity

G S Hotamisligil, X O Breakefield, G S Hotamisligil, X O Breakefield

Abstract

Monoamine oxidase (MAO) is a critical enzyme in the degradative deamination of biogenic amines throughout the body. Two biochemically distinct forms of the enzyme, A and B, are encoded in separate genes on the human X chromosome. In these studies we investigated the role of the structural gene for MAO-A in determining levels of activity in humans, as measured in cultured skin fibroblasts. The coding sequence of the mRNA for MAO-A was determined by first-strand cDNA synthesis, PCR amplification, and direct dideoxy sequencing. Two single-basepair substitutions were observed in cDNAs from cells with a 30-fold difference in activity levels. These two substitutions were in the third base of a triplet codon and hence did not affect the deduced amino acid sequence but did affect the presence or absence of restriction-enzyme sites for EcoRV and Fnu4HI, which could be elucidated on PCR fragments derived from genomic DNA or cDNAs. A third polymorphism for MspI in the noncoding region of the MAOA gene was also evaluated by Southern blot analysis using genomic DNA. Statistically significant associations were observed between the alleles for MAOA and levels of MAO activity in human male fibroblast lines. This association indicates that the MAOA gene itself is a major determinant of activity levels, apparently, in part, through noncoding, regulatory elements.

References

    1. Biol Psychiatry. 1990 Apr 15;27(8):911-22
    1. Science. 1985 Oct 11;230(4722):181-3
    1. Schizophr Bull. 1980;6(2):355-67
    1. Anal Biochem. 1981 Apr;112(2):295-8
    1. Am J Hum Genet. 1984 Jan;36(1):36-43
    1. Proc Natl Acad Sci U S A. 1982 Oct;79(20):6385-9
    1. Psychiatry Res. 1980 Jul;2(3):307-14
    1. Biochem Pharmacol. 1982 Dec 15;31(24):4061-6
    1. Biochem Genet. 1980 Jun;18(5-6):577-90
    1. J Neurochem. 1979 Jan;32(1):49-55
    1. Proc Natl Acad Sci U S A. 1977 Dec;74(12):5463-7
    1. Biochemistry. 1979 Nov 27;18(24):5294-9
    1. J Neurochem. 1978 Nov;31(5):1247-54
    1. Clin Chim Acta. 1977 Oct 15;80(2):317-26
    1. Biochem Pharmacol. 1977 May 1;26(9):853-8
    1. Science. 1976 Jun 4;192(4243):1018-20
    1. Acta Ophthalmol (Copenh). 1975 Mar;53(2):217-36
    1. J Clin Invest. 1988 Aug;82(2):739-43
    1. N Engl J Med. 1988 Jan 21;318(3):134-9
    1. J Histochem Cytochem. 1987 Jan;35(1):23-32
    1. Clin Genet. 1985 Oct;28(4):317-20
    1. Science. 1987 Jan 23;235(4787):481-5
    1. Neuron. 1989 Jan;2(1):1069-76
    1. Biotechniques. 1989 Apr;7(4):326-8, 331
    1. Nucleic Acids Res. 1989 Dec 25;17(24):10516
    1. J Neurochem. 1989 Jul;53(1):12-8
    1. Hum Genet. 1989 Dec;84(1):22-6
    1. Genomics. 1989 Aug;5(2):368-70
    1. Am J Hum Genet. 1989 Sep;45(3):424-34
    1. Biochem Pharmacol. 1963 Dec;12:1439-41
    1. J Neural Transm Gen Sect. 1991;83(1-2):1-12
    1. Pharmacol Ther. 1990;47(3):391-417
    1. J Neurochem. 1988 Oct;51(4):1321-4
    1. J Med Genet. 1988 Feb;25(2):73-8
    1. Science. 1988 Jan 29;239(4839):487-91
    1. Genomics. 1989 May;4(4):552-9
    1. Biochem J. 1989 Apr 15;259(2):407-13
    1. Genomics. 1988 Jul;3(1):53-8
    1. Proc Natl Acad Sci U S A. 1988 Jul;85(13):4934-8
    1. Cytogenet Cell Genet. 1986;42(4):219-24
    1. Cell Mol Neurobiol. 1986 Jun;6(2):121-50
    1. J Biol Chem. 1985 Oct 25;260(24):13199-207
    1. J Neurochem. 1990 Jan;54(1):242-7

Source: PubMed

3
Iratkozz fel